SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 498 filers reported holding SEAGEN INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,684,684 | +11.8% | 7,941 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $1,507,156 | -0.4% | 7,831 | +4.8% | 0.00% | 0.0% |
| Q1 2023 | $1,512,452 | +60.1% | 7,470 | +1.6% | 0.00% | 0.0% |
| Q4 2022 | $944,548 | -12.6% | 7,350 | -6.9% | 0.00% | 0.0% |
| Q3 2022 | $1,081,000 | -20.3% | 7,894 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $1,357,000 | +29.6% | 7,676 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $1,047,000 | -14.1% | 7,262 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $1,219,000 | -5.4% | 7,887 | +3.9% | 0.00% | 0.0% |
| Q3 2021 | $1,288,000 | +8.1% | 7,589 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $1,191,000 | +18.5% | 7,538 | +4.1% | 0.00% | 0.0% |
| Q1 2021 | $1,005,000 | -34.1% | 7,241 | -16.8% | 0.00% | -50.0% |
| Q4 2020 | $1,525,000 | – | 8,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |